LISATA THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 2287201, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2011-12-31) |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:02.546101+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c187f5f6-38fe-46d5-b21e-7e6728c3ef2d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001445305-12-002636 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:02.546101+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/accounts-payable/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c187f5f6-38fe-46d5-b21e-7e6728c3ef2d
History
- supersedes {"amount": 10237524, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001144204-12-028121)